NAS10027,087+1.72%S&P7,401+0.65%GOLD$4,073−1.00%BTC$75,828−0.15%VIX24.55−12.88%latest tape · as of 20:03 UTC
The Screen · Consumer Cyclical · Residential Construction
M/I Homes, Inc.
MHO · the NYSE · USD · Market cap $3.5B · 1,801 employees
M/I Homes, Inc., together with its subsidiaries, engages in the construction and sale of single-family residential homes in Ohio, Indiana, Illinois, Minnesota, Michigan, Florida, Texas, North Carolina, and Tennessee.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.02, read 2026-11-05
Ethical passes the values gate
Price134.32 USD
Fair value146.82
Ethical score70.0/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-11-04Read Markup128.84+4.3% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-28Read Distribution124.06+8.3% to today Markdown gives way to Distribution after a 12% slide in 4 weeks
2026-10-02Read Markdown140.34-4.3% to today ✓Accumulation gives way to Markdown after an 8% slide in 4 weeks
2026-09-05Read Accumulation152.29-11.8% to today Markup gives way to Accumulation while volume is distributing
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
M/I Homes, Inc. holds its Markup at $134.32. The statistical read favours the sellers, held for 374 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 374 days
Price at the screen
$134.32
Valuation
13.06 trailing · 12.30 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.67
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
21.56%
Below 33%
Interest-bearing debt is just 21.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
14.43%
Below 49%
Money owed to the company is 14.4% of assets, under the 49% limit.
Pass
Revenue purity
0.45%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
M/I Homes, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 22%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MHO's ethical verdict changes
Today MHO passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades at roughly a 9% discount to our $146.82 fair value.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 8.5% discount to the base estimate.
Where our models see it going: fair-value estimate $146.82, with a range of $135.00 to $173.29, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Homebuilder Looks Cheap But The Cycle May Bite
Picture a family buying their first house just as mortgage rates climb and buyers pull back. M/I Homes builds single-family homes across nine US states, yet revenue is already falling 6 percent and the business sits in a sector that rises and falls with interest rates and consumer confidence.
The shares trade at a forward P/E of 9.8 times with an 8 percent profit margin and 12 percent return on equity, numbers that appear attractive next to a modest 14 percent margin of safety to our fair value. We still pass. Low multiples on cyclical earnings often signal peak profits rather than a bargain, and the opportunity rating sits at none despite the ethical screen clearing cleanly.
Demand can turn quickly in residential construction, leaving thin margins exposed when volumes drop further. Three analysts see a median target near 165, but that offers little protection against a housing slowdown. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MHO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup · changed$128.84+3.9%Entry 16
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. Insiders have been net sellers over the past quarter.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160.
2026-10-21Markdown$124.06-1.6%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$126.02+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$126.02+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$126.02+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markdown$126.02+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markdown$126.02-1.4%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markdown$127.82+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markdown$127.82-8.9%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (2 analysts) rates it none, with a mean price target of $160. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
